State bans on conversion therapy remain enforceable after the US Supreme Court’s ruling, but experts warn the decision may invite new legal challenges.

A novel mu-opioid receptor agonist showed strong analgesia without respiratory depression, tolerance, or significant ...

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in RRMS may affect ...

Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.

Dr Chu-Yueh Guo prepares to discover how the latest diagnostic criteria and breakthrough treatments are reshaping the ...

"I find the consistency across age, race, BMI, and glycemic status more clinically exciting than the sex difference," said ...

Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security.

In allogeneic haematopoietic cell transplant recipients, ciprofloxacin prophylaxis may reduce bloodstream infections but is ...

Adalimumab and ixekizumab show comparable effectiveness in improving joint outcomes and achieving remission in patients with psoriatic arthritis over 12 months, according to a real-world study.

Under NICE’s final draft guidance, vorasidenib (Voranigo, Servier Laboratories) is indicated for patients with grade 2 astrocytoma or oligodendroglioma with susceptible isocitrate dehydrogenase (IDH1 ...

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Anemia affects more than 1 in 4 pregnant individuals in the US, with prevalence increasing from prenatal care initiation to ...